Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurovascular Coupling | 7 | 2024 | 154 | 0.980 |
Why?
|
| Spectroscopy, Near-Infrared | 5 | 2024 | 75 | 0.950 |
Why?
|
| Aging | 8 | 2025 | 1019 | 0.940 |
Why?
|
| Cognitive Dysfunction | 6 | 2024 | 271 | 0.940 |
Why?
|
| Motor Cortex | 1 | 2021 | 48 | 0.680 |
Why?
|
| Brain | 8 | 2025 | 770 | 0.620 |
Why?
|
| Oxidative Stress | 2 | 2025 | 677 | 0.580 |
Why?
|
| Cognition | 4 | 2025 | 331 | 0.500 |
Why?
|
| Brain Mapping | 4 | 2021 | 207 | 0.480 |
Why?
|
| Cerebrovascular Circulation | 5 | 2024 | 225 | 0.420 |
Why?
|
| Sleep Deprivation | 2 | 2021 | 28 | 0.350 |
Why?
|
| Peripheral Arterial Disease | 2 | 2025 | 144 | 0.340 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 225 | 0.320 |
Why?
|
| Rest | 2 | 2019 | 96 | 0.270 |
Why?
|
| Aged | 8 | 2025 | 5606 | 0.270 |
Why?
|
| Humans | 18 | 2025 | 28983 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 843 | 0.250 |
Why?
|
| Niacinamide | 1 | 2025 | 32 | 0.220 |
Why?
|
| Smartphone | 1 | 2025 | 80 | 0.220 |
Why?
|
| Electroencephalography | 3 | 2021 | 143 | 0.220 |
Why?
|
| Cancer Survivors | 1 | 2025 | 72 | 0.220 |
Why?
|
| NAD | 1 | 2025 | 104 | 0.210 |
Why?
|
| Cellular Senescence | 1 | 2025 | 141 | 0.210 |
Why?
|
| Transcriptome | 2 | 2025 | 232 | 0.210 |
Why?
|
| Heart | 1 | 2025 | 232 | 0.210 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 2065 | 0.210 |
Why?
|
| Hemodynamics | 2 | 2021 | 221 | 0.210 |
Why?
|
| Memory, Short-Term | 2 | 2021 | 64 | 0.200 |
Why?
|
| Hyperhomocysteinemia | 1 | 2023 | 29 | 0.200 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2023 | 14 | 0.200 |
Why?
|
| Male | 9 | 2025 | 13978 | 0.190 |
Why?
|
| Deoxyguanosine | 1 | 2022 | 14 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2025 | 273 | 0.190 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1004 | 0.190 |
Why?
|
| White Matter | 1 | 2023 | 90 | 0.190 |
Why?
|
| Research | 1 | 2022 | 93 | 0.180 |
Why?
|
| Middle Aged | 5 | 2025 | 7425 | 0.180 |
Why?
|
| Prospective Studies | 2 | 2023 | 1281 | 0.180 |
Why?
|
| Parabiosis | 1 | 2022 | 17 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 344 | 0.180 |
Why?
|
| Dementia | 1 | 2023 | 97 | 0.180 |
Why?
|
| Biological Products | 1 | 2022 | 67 | 0.180 |
Why?
|
| Young Adult | 4 | 2022 | 2842 | 0.180 |
Why?
|
| Aniline Compounds | 1 | 2021 | 23 | 0.180 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 80 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 41 | 0.170 |
Why?
|
| Exercise | 1 | 2025 | 498 | 0.170 |
Why?
|
| Hyperemia | 1 | 2021 | 40 | 0.170 |
Why?
|
| Sulfonamides | 1 | 2021 | 73 | 0.170 |
Why?
|
| Nerve Net | 2 | 2020 | 112 | 0.170 |
Why?
|
| Schizophrenia | 1 | 2021 | 51 | 0.160 |
Why?
|
| Hypertension | 1 | 2023 | 309 | 0.160 |
Why?
|
| Connectome | 1 | 2019 | 88 | 0.150 |
Why?
|
| Biomarkers | 1 | 2022 | 782 | 0.140 |
Why?
|
| Mice | 6 | 2025 | 4812 | 0.140 |
Why?
|
| Fractals | 1 | 2018 | 1 | 0.140 |
Why?
|
| Adult | 4 | 2022 | 8045 | 0.130 |
Why?
|
| Endothelium, Vascular | 3 | 2025 | 334 | 0.130 |
Why?
|
| Neoplasms | 1 | 2025 | 875 | 0.120 |
Why?
|
| Female | 7 | 2025 | 15682 | 0.110 |
Why?
|
| Animals | 6 | 2025 | 10710 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 1660 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2025 | 464 | 0.100 |
Why?
|
| Cerebral Cortex | 2 | 2021 | 136 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2023 | 249 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2023 | 373 | 0.070 |
Why?
|
| Pyridinium Compounds | 1 | 2025 | 27 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2025 | 191 | 0.060 |
Why?
|
| Fasting | 1 | 2024 | 91 | 0.050 |
Why?
|
| Methionine | 1 | 2023 | 38 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 465 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 55 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 93 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 200 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2022 | 41 | 0.050 |
Why?
|
| Arterioles | 1 | 2022 | 61 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 429 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2021 | 11 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 205 | 0.040 |
Why?
|
| Diet | 1 | 2023 | 241 | 0.040 |
Why?
|
| Quality of Life | 1 | 2025 | 521 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 479 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2021 | 12 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2021 | 35 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 410 | 0.040 |
Why?
|
| Reaction Time | 1 | 2021 | 95 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2021 | 34 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 68 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2021 | 16 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2021 | 54 | 0.040 |
Why?
|
| Gait | 1 | 2021 | 61 | 0.040 |
Why?
|
| Entropy | 1 | 2019 | 7 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 513 | 0.040 |
Why?
|
| Brain Waves | 1 | 2019 | 11 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 739 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2019 | 35 | 0.040 |
Why?
|
| Neurons | 1 | 2021 | 297 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 686 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2019 | 122 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 2019 | 57 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 50 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 1510 | 0.030 |
Why?
|